Besides, CXCL12-KDEL retention protein was used to block colon cancer cells, resulting in repression of the signaling involved in CXCR4 and a significant reduction in the metastatic cancer growth48. This evidence concerns the gene CXCR4 and metastatic malignant neoplasm.